Data / Form D filings / Carcinotech Ltd.
Carcinotech Ltd.: Form D filing
Carcinotech Ltd., a biotechnology company in Scotland, United Kingdom, filed a Form D with the SEC in 2024. The latest, on January 3, 2024, reports $508,454 sold of a $508,454 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ROSLIN INNOVATION CENTRE, EASTER BUSH CAMPUS, EDINBURGH MIDLOTHIAN, Scotland, United Kingdom, EH25
- Phone
- +4401316519678
- Industry
- Biotechnology
- Entity type
- Other (a private limited company incorporated under the laws of Scotland)
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2005300
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 3, 2024 | New notice | $508,454 | $508,454 | 1 | Dec 22, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Albert Nicholl | Director | |
| Ishani Malhotra | Executive Officer, Director | |
| Ian David Waddell | Director |
Every Form D from the week of Jan 1, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Carcinotech Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.